HEALTH chiefs have unveiled “significant” changes to the childhood vaccination schedule following a sharp rise in cases of a ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended Novartis’ meningitis B vaccine, Bexsero, for approval for use in patients aged 2 months or older.

for people ages 16 to 23 for whom a vaccine protecting against meningitis B is recommended, and for people ages 10 and older at increased risk of developing meningococcal disease because of ...

In the wake of multiple cases of meningitis B on the University of Wisconsin campus, health officials are holding five days of mass vaccinations. Even students who have already been immunized with the ...

Meningococcal vaccination helps prevent bacterial meningitis and other types of meningococcal ... in the United States are caused by serogroups B, C, and Y, reports the CDC. Outbreaks of serogroup ...

The Government has announced ‘significant’ changes to the childhood vaccination schedule, including a new routine appointment ...

The ACIP voted 15-0 to recommend that Penmenvy (MenABCWY), GSK’s newly-approved pentavalent meningococcal vaccine, can be used when vaccines for the A, C, W, and Y strains and B strains are ...

The advisory panel to the Centers for Disease Control and Prevention had made recommendations regarding the use of separate ...

ATLANTA (AP) — A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis.